Italia markets closed

BMY Aug 2024 45.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,8200-0,0300 (-1,62%)
Alla chiusura: 03:25PM EDT
Schermo intero
Chiusura precedente1,8500
Aperto2,0600
Denaro1,8600
Lettera1,8900
Prezzo d'esercizio45,00
Scadenza2024-08-16
Min-Max giorno1,8200 - 2,0900
Contratto - Min-MaxN/D
Volume353
Open Interest3,66k
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri